Frontlight ResearchEarly access
Trial site
Michigan Med University of Michigan
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia2 trials
- Myeloproliferative neoplasms2 trials
- Acute lymphoblastic leukaemia1 trial
- ANCA-associated vasculitis1 trial
- Childhood cancers1 trial
- Follicular lymphoma1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Phase 41 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals6 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026